21 October 2019 | News
The affordability and accessibility of healthcare remains at the core of partnerships between the Indian and the Dutch stakeholders
Life Sciences and Healthcare (LSH) is a priority sector under bilateral collaboration between India and the Netherlands. Growing market opportunities in India, combined with the Netherlands’ strengths in areas such as Therapeutics & Vaccines, Medtech and Digital Health create excellent opportunities for partnerships that address shared societal challenges with smart solutions and make India a valuable partner for the Dutch LSH Sector. The affordability and accessibility of healthcare remains at the core of partnerships between the Indian and the Dutch stakeholders.
On the 17th and 18th of October, more than 80 companies and knowledge institutes from the Netherlands in the fields of Life Sciences & Healthcare (LSH) and Horticulture & Agriculture visited Bengaluru. Heading the delegation were Dutch Minister for Medical Care and Sport, Bruno Bruins, Chair of the Top Sector Life Sciences & Health, Carmen van Vilsteren, Vice Minister of Agriculture, Marjolijn Sonnema and Chairman of the Topsector Horticulture & Starting Materials, Loek Hermans.
To encourage partnerships around important themes of affordability and accessibility, a Healthcare Seminar was organised at Hotel Four Seasons in Bengaluru that brought together government officials, healthcare practitioners, med-tech companies, IT companies, academic institutes and start-ups. The Ministerial and business delegation also visited Philips Innovation Campus, Centre for Cellular & Molecular Platforms (C-CAMP), Narayana Health City and Anthem Biosciences.
4 MoUs were signed during a Holland Trade Reception hosted by Consul-General of the kingdom of the Netherlands in Bengaluru, Gert Heijkoop. The overview is given below:
Calling Bengaluru, Brainport of India, Dutch Minister for Medical Care and Sport, Bruno Bruins said, "The State of Karnataka is an important partner for the Netherlands regarding health. It is impressive to see how the Bangalore biotech cluster is helping to drive new scientific breakthroughs and innovations. Not only on antimicrobial resistance but also on digital health, medical devices and diagnostics. I see a lot of opportunities for and positive energy between Dutch and Indian companies and knowledge institutes to work together on affordable and accessible healthcare for all. A challenge not only in the Netherlands but also in India. Building up a healthcare infrastructure for everyone is a hard nut to crack. At the same time there are unique opportunities by using new data-technology, ICT and e-health. Working together on our mutual challenges will help us both to improve the national and global health”.